HIGH DOSE VERSUS INTERMEDIATE DOSE CYTOSINE ARABINOSIDE COMBINED WITH MITOXANTRONE FOR THE TREATMENT OF RELAPSED AND REFRACTORY ACUTE MYELOID LEUKEMIA: RESULTS OF AN AGE ADJUSTED RANDOMIZED COMPARISON

HIDDEMANN, W., AUL, C., & MASCHMEYER, G.. (1993). HIGH DOSE VERSUS INTERMEDIATE DOSE CYTOSINE ARABINOSIDE COMBINED WITH MITOXANTRONE FOR THE TREATMENT OF RELAPSED AND REFRACTORY ACUTE MYELOID LEUKEMIA: RESULTS OF AN AGE ADJUSTED RANDOMIZED COMPARISON. LEUKEMIA AND LYMPHOMA, 10(SUPPL), 133-137. SID. https://sid.ir/paper/555620/en

HIDDEMANN W., AUL C., MASCHMEYER G.. HIGH DOSE VERSUS INTERMEDIATE DOSE CYTOSINE ARABINOSIDE COMBINED WITH MITOXANTRONE FOR THE TREATMENT OF RELAPSED AND REFRACTORY ACUTE MYELOID LEUKEMIA: RESULTS OF AN AGE ADJUSTED RANDOMIZED COMPARISON. LEUKEMIA AND LYMPHOMA[Internet]. 1993;10(SUPPL):133-137. Available from: https://sid.ir/paper/555620/en

W. HIDDEMANN, C. AUL, and G. MASCHMEYER, “HIGH DOSE VERSUS INTERMEDIATE DOSE CYTOSINE ARABINOSIDE COMBINED WITH MITOXANTRONE FOR THE TREATMENT OF RELAPSED AND REFRACTORY ACUTE MYELOID LEUKEMIA: RESULTS OF AN AGE ADJUSTED RANDOMIZED COMPARISON,” LEUKEMIA AND LYMPHOMA, vol. 10, no. SUPPL, pp. 133–137, 1993, [Online]. Available: https://sid.ir/paper/555620/en